Xylem

Q2 FY2026 EarningsQ2 FY2026 results were mixed as revenue of $2.34B was largely in-line with consensus, while profitability significantly outperformed. Adjusted EPS of $1.46 beat the $1.34 consensus by 9.0%, driven by strong EBITDA margin expansion (up 150 bps YoY to 23.3%) and effective cost management. While organic revenue growth was modest at 1%, total orders surged 42% YoY to $3.1B, signaling robust future demand. Management raised the full-year adjusted EPS guidance to $5.55–$5.70, well above the previous range, despite slightly tightening the revenue growth outlook.